The pulmonary vasodilator properties of potassium channel opening drugs

General Pharmacology

Volumn 27, Issue 4, 1996, Pages 599-605

  Wanstall, Janet C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Hypoxia; Potassium channel openers; Pulmonary hypertension; Pulmonary vasodilators

Indexed keywords

POTASSIUM CHANNEL STIMULATING AGENT; VASODILATOR AGENT;

CHANNEL GATING; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; VASODILATATION;

EID: 0030176194     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02044-6     Document Type: Review

References (92)

1. Anabuki J., Hori M., Ozaki H., Kato I. and Karaki H. (1990) Mechanisms of pinacidil-induced vasodilatation. Europ. J. Pharmacol. 190, 373-379.
2. Andersson K.-E. (1992) Clinical pharmacology of potassium channel openers. Pharmacol. Toxicol. 70, 244-254.
3. 2 sensor in rat pulmonary vasculature. Circ. Res. 73, 1100-1112.
4. ATP openers. J. Cardiovasc. Pharmacol. 24 (Suppl. 4), S12-S17.
5. Beech D. J., Zhang H., Nakao K. and Bolton T. B. (1993) K channel activation by nucleoside diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br. J. Pharmacol. 110, 573-582.
6. Bishop M. J. and Cheney F. W. (1983) Comparison of the effects of minoxidil and nifedipine on hypoxic pulmonary vasoconstriction in dogs. J. Cardiovasc. Pharmacol. 5, 184-189.
7. ATP channels. Clin. Exp. Pharmacol. Physiol. 21, 583-597.
8. Chan N. S., McLay J. and Kenmure A. C. F. (1987) Reversibility of primary pulmonary hypertension during 6 years of treatment with oral diazoxide. Br. Heart J. 57, 207-209.
9. + channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide. J. Appl. Physiol. 73, 188-194.
10. Chappell L. C., Leach R. M. and Twort C. H. C. (1990) Differential vasorelaxant effects of BRL 38227 in isolated large and small pulmonary vessels of the rat. J. Physiol. 429, 74P.
11. Chen G., Suzuki H. and Weston A. H. (1988) Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95, 1165-1174.
12. + channels mediate vasodilation produced by lemakalim in rabbit pulmonary artery. Am. J. Physiol. 264, H1907-1915.
13. + channels regulate resting potential of pulmonary arterial smooth muscle cells. Am. J. Physiol. 262, H916-H920.
14. Cook N. S. and Chapman I. D. (1993) Therapeutic potential of potassium channel openers in peripheral vascular disease and asthma. Cardiovasc. Drugs Therap. 7, 555-563.
15. + channels in pancreatic β cells. Nature 311, 271-273.
16. Cornfield D. N., McQueston J. A., McMurty I. F., Rodman D. M. and Abman S. H. (1992) Role of ATP-sensitive potassium channels in ovine fetal pulmonary vascular tone. Am. J. Physiol. 263, H1363-H1368.
17. Daut J., Willibald M.-R., von Beckerath N., Mehrke G., Gunther K. and Goedel-Meinen L. (1990) Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science (Washington, DC) 247, 1341-1344.
18. Dinh-Xuan A. T., Higenbottam T. W., Scott J. P. and Wallwork J. (1990) Primary pulmonary hypertension: diagnosis, medical and surgical treatment. Respir. Med. 84, 189-197.
19. + channel openers on airways and pulmonary circulation in the isolated guinea-pig lung. Europ. J. Pharmacol. 239, 141-147.
20. + channel openers, aprikalim and pinacidil, on hypoxic pulmonary vasoconstriction. Europ. J. Pharmacol. 263, 17-23.
21. + channel openers. TIPS 11, 417-422.
22. Edwards G. and Weston A. H. (1993) The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol. 33, 597-637.
23. Eltze M. (1989) Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery. Europ. J. Pharmacol. 165, 231-239.
24. Furukawa K., Itoh T., Kajiwara M., Kitamura K., Suzuki H., Ito Y. and Kuriyama H. (1981) Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J. Pharmacol. Exp. Therap. 218, 248-259.
25. + channels: pharmacologic properties, regulation and therapeutic potential. Drug Develop. Res. 28, 95-127.
26. Hassessian H., Bodin P. and Burnstock G. (1993) Blockade by glibenclamide of the flow-evoked endothelial release of ATP that contributes to vasodilatation in the pulmonary vascular bed of the rat. Br. J. Pharmacol. 109, 466-472.
27. Hasunuma K., Rodman D. M., O'Brien R. F. and McMurtry I. F. (1990) Endothelin 1 causes pulmonary vasodilation in rats. Am. J. Physiol. 259, H48-H54.
28. Hermsmeyer R. K. (1988) Pinacidil actions on ion channels in vascular smooth muscle. J. Cardiovasc. Pharmacol. 12 (Suppl. 2): S17-S22.
29. Higenbottam T. W. (1987) The place of prostacyclin in the clinical management of primary pulmonary hypertension. Am. Rev. Resp. Dis. 136, 782-785.
30. Higenbottam T. W., Wheeldon D., Wells F. C. and Wallwork J. (1984) Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet i, 1046-1047.
31. Honey M., Cotter L., Davies N. and Denison D. (1980) Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax 35, 269-276.
32. Hood J. S., McMahon T. J. and Kadowitz P. J. (1991a) Influence of lemakalim on the pulmonary vascular bed of the cat. Europ. J. Pharmacol. 202, 101-104.
33. ATP channel. Europ. J. Pharmacol. 202, 121-124.
34. Kajioka S., Nakashima M., Kitamura K. and Kuriyama H. (1991) Mechanisms of vasodilatation induced by potassium-channel activators. Clin. Sci. 81, 129-139.
35. + channel-mediated vasorelaxation is upregulated in sheep pulmonary arteries during pulmonary hypertension to compensate for impaired NO production. Can. J. Physiol. Pharmacol. 72, P 1.7.30 (Abstract).
36. 86Rb flux studies in rabbit isolated vascular smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 343, 70-75.
37. Kukovetz W. R., Holzmann S., Braida C. and Poch G. (1991) Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J. Cardiovasc. Pharmacol. 17, 627-633.
38. Lawson K., Barras M., Zazzi-Sudriez E., Martin D. J., Armstrong J. M. and Hicks P. E. (1992) Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers. Br. J. Pharmacol. 107, 58-65.
39. Lippton H. L., Cohen G. A., McMurtry I. F. and Hyman A. L. (1991) Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J. Appl. Physiol. 70, 947-952.
40. 1 treatment of pulmonary hypertension. Am. Rev. Resp. Dis. 136, 773-776.
41. Longman S. D. and Hamilton T. C. (1992) Potassium channel activator drugs: mechanisms of action, pharmacological properties and therapeutic potential. Med. Res. Rev. 12, 73-148.
42. Martin D. J., Gelotte M., Armstrong J. M. and Hicks P. E. (1990) Pulmonary and systemic haemodynamic effects of cromakalim in conditions of normoxia and hypoxia in dogs. J. Auton. Pharmacol. 10, 261-272.
43. McLeod A. A. and Jewitt D. E. (1986) Drug treatment of primary pulmonary hypertension. Drugs 31, 177-184.
44. + channel-dependent as well as independent components of pinacidil-induced vasodilation. J. Pharmacol. Exp. Therap. 256, 492-499.
45. Mellemkjaer S., Nielsen-Kudsk J. E., Nielsen C. B. and Siggaard C. (1989) A comparison of the relaxant effects of pinacidil in guinea-pig trachea, aorta and pulmonary artery. Europ. J. Pharmacol. 167, 275-280.
46. Michael J. R. and Summer W. R. (1985) Pulmonary hypertension. Lung 163, 65-82.
47. ATP channels. Am. J. Physiol. 260, H957-H966.
48. Miyata N., Tsuchida K. and Otomo S. (1990) Functional changes in potassium channels in carotid arteries from stroke-prone spontaneously hypertensive rats. Europ. J. Pharmacol. 182, 209-210.
49. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ. Res. 70, 612-616.
50. Nielsen-Kudsk J. E. and Bang L. (1991) Effects of pinacidil and other cyanoguanidine derivatives on guinea-pig isolated trachea, aorta and pulmonary artery. Europ. J. Pharmacol. 201, 97-102.
51. Noack T. E. D., Wards G., Deitmer P. and Weston A. H. (1992) Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227). Br. J. Pharmacol. 107, 945-955.
52. 2a or endothelin. Br. J. Pharmacol. 102, 311-316.
53. O'Donnell S. R., Wanstall J. C. and Zeng X.-P. (1990) Pinacidil antagonism of endothelin-induced contractions of smooth muscle in the lungs: differences between tracheal and pulmonary artery preparations. J. Pharmacol. Exp. Therap. 252, 1318-1323.
54. Oka M., Morris K. G. and McMurtry I. F. (1993) NIP-121 is more effective than nifedipine in acutely reversing chronic pulmonary hypertension. J. Appl. Physiol. 75, 1075-1080.
55. ATP-channel activation causes marked vasodilation in the hypertensive neonatal pig lung. Am. J. Physiol. 263, H1532-H1536.
56. Post J. M., Hume J. R., Archer S. L. and Weir E. K. (1992) Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J. Physiol. 262, C882-C890.
57. + channels? TIPS. 14, 332-337.
58. + channels. TIPS 10, 431-435.
59. Reeves J. T., Groves B. M. and Turkevich D. (1986) The case for treatment of selected patients with primary pulmonary hypertension. Am. Rev. Resp. Dis. 134, 342-346.
60. Reid L. M. (1979) The pulmonary circulation: remodelling in growth and disease. Am. Rev. Resp. Dis. 119, 531-546.
61. Reid L. M. (1993) An overview of the cellular changes in pulmonary hypertension. Europ. Resp. Rev. 3 (Review 16), 564-568.
62. Rich S. and Brundage B. H. (1987) High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 76, 135-141.
63. Rich S., Kaufmann E. and Levy P. S. (1992) The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 327, 76-81.
64. + channel openers, a class of drugs with vasorelaxant and cardioprotective properties. Life Sci. 47, 1693-1705.
65. Robertson D. W. and Steinberg M. I. (1990) Potassium channel modulators: scientific applications and therapeutic promise. J. Med. Chem. 33, 1533-1541.
66. Robertson T. P., Priest R., Leach R. M. and Ward T. P. (1993) Chronic hypoxia results in depolarisation of the resting membrane potential of isolated small pulmonary arteries of the rat. J. Physiol. Lond. 467, 54P.
67. + channel-mediated relaxation. Am. J. Physiol. 263, L88-L94.
68. Rounds S. and Hill N. S. (1984) Pulmonary hypertensive diseases. Chest 85, 397-405.
69. Royston D. (1993) Inhalational agents for pulmonary hypertension. Lancet 342, 941-942.
70. Savineau J.-P. and Marthan R. (1993) Effect of cromakalim on KCl-noradrenaline- and angiotensin II-induced contractions in the rat pulmonary artery. Pulm. Pharmacol. 6, 41-48.
71. + current in rat pulmonary artery muscle cells. Am. J. Physiol. 266, H365-H370.
72. + channels in arterial smooth muscle. Science (Washington, DC) 245, 177-180.
73. Suzuki H. and Twarog B. M. (1982) Membrane properties of smooth muscle cells in pulmonary hypertensive rats. Am. J. Physiol. 242, H907-H915.
74. Twarog B. M., Takuno H., Petrou B. A., Wahlqvist I., Marcus M. S. and Campbell G. L. (1988) Pathogenesis of pulmonary hypertension in the rat model. Chest 93, S100-S101.
75. Wang S. W. S., Pohl J. E. F., Rowlands D. J. and Wade E. G. (1978) Diazoxide in treatment of primary pulmonary hypertension. Br. Heart J. 40, 572-574.
76. Wanstall J. C. (1994) In vitro hypoxia attenuates vasorelaxation by potassium channel opening drugs and nitroprusside in isolated pulmonary arteries from rats. J. Pharmacol. Exp. Therap. 271, 845-851.
77. Wanstall J. C. (1995) Vasorelaxation by pinacidil in isolated perfused lungs is enhanced in rats with hypoxic pulmonary hypertension but is dependent on the constrictor. Physiol. Res. 44, 1-6.
78. Wanstall J. C., Kay C. S. and O'Donnell S. R. (1994) Pinacidil-induced relaxation in pulmonary arteries isolated from pulmonary hypertensive and normotensive rats and pre-contracted with different spasmogens. Pulm. Pharmacol. 7, 401-408.
79. Wanstall J. C. and O'Brien E. (1995) In vitro hypoxia and levcromakalim relax rat pulmonary artery by a common mechanism. Pharmacol. Res. 31 (Suppl.), 310.
80. Wanstall J. C. and O'Donnell S. R. (1992) Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br. J. Pharmacol. 105, 152-158.
81. Weir E. K., Chidsey C. A., Weil J. V. and Grover R. F. (1976) Minoxidil reduces pulmonary vascular resistance in dogs and cattle. J. Lab. Clin. Med. 88, 885-893.
82. Weir E. K., Rubin L. J., Ayres S. M., Bergofsky E. H., Brundage B. H., Detre K. M., Elliott C. G., Fishman A. P., Goldring R. M., Groves B. M., Kernis J. T., Koerner S. K., Levy P. S., Pietra G. G., Reid L. M., Rich S.,Vreim C. E., Williams G. W. and Wu M. (1989) The acute administration of vasodilators in primary pulmonary hypertension. Am. Rev. Resp. Dis. 140, 1623-1630.
83. 86Rb efflux in rat blood vessels. Br. J. Pharmacol. 88, 121-128.
84. Weston A. H. and Edwards G. (1992) Recent progress in potassium channel opener pharmacology. Biochem. Pharmacol. 43, 47-54.
85. Widimsky J. (1990) Calcium channel blockers in the treatment of hypoxic pulmonary hypertension. Prog. Respir. Res. 26, 110-118.
86. + channels modulate vasoconstrictor responses to severe hypoxia in isolated ferret lungs. J. Clin. Invest. 88, 500-504.
87. Wong J., Vanderford P. A., Fineman J. R., Chang R. and Soifer S. J. (1993) Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb. Am. J. Physiol. 265, H1318-H1325.
88. b receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension. J. Cardiovasc. Pharmacol. 25, 207-215.
89. Yanagisawa T., Teshigawara T. and Taira N. (1990) Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicroandil. Br. J. Pharmacol. 101, 157-165.
90. Yuan X.-J., Goldman W. F., Tod M. L., Rubin L. J. and Blaustein M. P. (1993) Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am. J. Physiol. 264, L116-L123.
91. Zhang H. and Bolton T. B. (1995) Activation by intracellular GDP, metabolic inhibition and pinacidil of a glibenclamide-sensitive K-channel in smooth muscle cells of rat mesenteric artery. Br. J. Pharmacol. 114, 662-672.
92. 2a-induced contractions in isolated rat pulmonary artery. J. Pharmacol. Exp. Therap. 271, 326-333.